DelfaGLP-1 Atlas

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

3

Trials led

1

Active

666

Total enrollment

2

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
1
Not applicable
2

Trials by status

Recruiting
1
Unknown
2

Trials led

Retrospective Analysis for Patients With Metabolic Syndrome—not applicableUnknown400
Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial DiseaseHbA1c ≤14%Ph 4Unknown200
Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With ObesityBMI ≥30not applicableRecruiting66